Market Cap 32.19M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 131,300
Avg Vol 228,182
Day's Range N/A - N/A
Shares Out 8.70M
Stochastic %K 93%
Beta 1.15
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
MikeTechnician
MikeTechnician Jul. 16 at 1:43 PM
$BCTX continues to expand pivotal Phase 3 Bria-IMT study in metastatic breast cancer, with Sunnybrook’s Odette Cancer Centre now its first Canadian clinical site. Trial now includes 80+ active sites across 15 U.S. states and Canada. #Biotech #Cancer News: https://bit.ly/4aUowNn
0 · Reply
prismmarketview
prismmarketview Jul. 16 at 11:49 AM
BriaCell Therapeutics (NASDAQ: $BCTX) just opened its first Canadian site at Sunnybrook in Toronto for its pivotal Phase 3 Bria‑IMT™ trial in metastatic breast cancer, adding to a growing network of North American centers running a Fast Track‑designated study that could support full approval if survival data stay positive. https://prismmarketview.com/companies/briacell-therapeutics-corp/#news
1 · Reply
MarkeTimer
MarkeTimer Jul. 16 at 11:42 AM
$BCTX Tomorrows press release: bad dental hygiene causes cavities.
0 · Reply
STACKD0E
STACKD0E Jul. 16 at 11:41 AM
0 · Reply
SmallCapVoice
SmallCapVoice Jul. 16 at 11:33 AM
$BCTX BriaCell opened its first Canadian site at Sunnybrook’s Odette Cancer Centre for its pivotal Phase 3 metastatic breast cancer trial, expanding access to Bria-IMT as the study gains momentum and is featured in Nature Medicine as one of “Eleven clinical trials that will shape medicine in 2026.” https://www.globenewswire.com/news-release/2026/07/16/3328357/0/en/briacell-opens-first-canadian-site-sunnybrook-for-pivotal-phase-3-trial-in-metastatic-breast-cancer.html
0 · Reply
letsdodiz
letsdodiz Jul. 16 at 2:02 AM
$BCTX Briacell management has been a low effort team in the last 2-3 years. So to come up with these commercialization PRs l means something. It’s great to see these news while we wait.
0 · Reply
_gatti_
_gatti_ Jul. 15 at 8:52 PM
$BCTX market is sleeping on this. I guess people will buy when this is over $5 . I would like to see some institution buying based on the commercialization news
1 · Reply
rp6577
rp6577 Jul. 15 at 8:43 PM
$BCTX I don’t know about you but I’m pumped $XBI
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 15 at 8:08 PM
$BCTX if you re into biotech, this is a no-brainer. Low market cap. Positive signs fase 3 will be good. Large potential market. Enough cash to go into 2027.
0 · Reply
EscapePlan
EscapePlan Jul. 15 at 6:37 PM
$BCTX Would be nice if this could get above $4 and hold for a bit. Volume is not particularly high, but there seems to be a little confidence that we are going to see a positive update. Look anyway, find any comparison, ask AI, you will get the same answer. If we get a positive update this is going to flip up into the 10s, and then once we get the next BLA etc buy out is highly likely at 20-30+. Still some way to go, probably some more dilution after the readout to get through the next FDA hurdles, but massive derisking and huge upside if (hopefully when) we get the positive interim readout Tempting to buy more warrants at this point....
1 · Reply
Latest News on BCTX
BriaCell announces Odette Cancer Centre joins Bria-IMT trial

2026-07-16T11:40:48.000Z - 2 hours ago

BriaCell announces Odette Cancer Centre joins Bria-IMT trial


BriaCell enters MoU with Uneedle for microneedle technology

2026-06-25T11:45:30.000Z - 21 days ago

BriaCell enters MoU with Uneedle for microneedle technology


BriaCell Therapeutics Announces Closing of Offering

Tue, 02 Jun 2026 16:05:00 -0400 - 6 weeks ago

BriaCell Therapeutics Announces Closing of Offering


BriaCell Presents Positive Clinical Data at ASCO 2026

Mon, 01 Jun 2026 07:30:00 -0400 - 6 weeks ago

BriaCell Presents Positive Clinical Data at ASCO 2026


BriaCell Therapeutics Announces Pricing of Offering

Sun, 31 May 2026 19:59:00 -0400 - 6 weeks ago

BriaCell Therapeutics Announces Pricing of Offering


BriaCell announces data from Bria-IMT at ASCO 2026

2026-05-22T11:49:02.000Z - 7 weeks ago

BriaCell announces data from Bria-IMT at ASCO 2026


BriaCell adds Penn Medicine as Phase 3 breast cancer study site

2026-05-13T14:41:55.000Z - 2 months ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site


BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Tue, 12 May 2026 07:30:00 -0400 - 2 months ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients


BriaCell receives FDA clearance to initiate Bria-BRES+ trial

2026-05-07T04:03:56.000Z - 2 months ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial


BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Mon, 27 Apr 2026 07:30:00 -0400 - 2 months ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026


BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T13:28:43.000Z - 3 months ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting


BriaCell presents anti-cancer activity of Bria-OTS

2026-04-21T11:54:23.000Z - 3 months ago

BriaCell presents anti-cancer activity of Bria-OTS


BriaCell to present four posters at the 2026 AACR

2026-03-18T11:42:55.000Z - 4 months ago

BriaCell to present four posters at the 2026 AACR


BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 4 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting


BriaCell Therapeutics trading resumes

2026-01-13T14:41:11.000Z - 6 months ago

BriaCell Therapeutics trading resumes


BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:35:29.000Z - 6 months ago

BriaCell Therapeutics trading halted, volatility trading pause


BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 9 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025


BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 21, 2025, 12:00 PM EDT - 11 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation


MikeTechnician
MikeTechnician Jul. 16 at 1:43 PM
$BCTX continues to expand pivotal Phase 3 Bria-IMT study in metastatic breast cancer, with Sunnybrook’s Odette Cancer Centre now its first Canadian clinical site. Trial now includes 80+ active sites across 15 U.S. states and Canada. #Biotech #Cancer News: https://bit.ly/4aUowNn
0 · Reply
prismmarketview
prismmarketview Jul. 16 at 11:49 AM
BriaCell Therapeutics (NASDAQ: $BCTX) just opened its first Canadian site at Sunnybrook in Toronto for its pivotal Phase 3 Bria‑IMT™ trial in metastatic breast cancer, adding to a growing network of North American centers running a Fast Track‑designated study that could support full approval if survival data stay positive. https://prismmarketview.com/companies/briacell-therapeutics-corp/#news
1 · Reply
MarkeTimer
MarkeTimer Jul. 16 at 11:42 AM
$BCTX Tomorrows press release: bad dental hygiene causes cavities.
0 · Reply
STACKD0E
STACKD0E Jul. 16 at 11:41 AM
0 · Reply
SmallCapVoice
SmallCapVoice Jul. 16 at 11:33 AM
$BCTX BriaCell opened its first Canadian site at Sunnybrook’s Odette Cancer Centre for its pivotal Phase 3 metastatic breast cancer trial, expanding access to Bria-IMT as the study gains momentum and is featured in Nature Medicine as one of “Eleven clinical trials that will shape medicine in 2026.” https://www.globenewswire.com/news-release/2026/07/16/3328357/0/en/briacell-opens-first-canadian-site-sunnybrook-for-pivotal-phase-3-trial-in-metastatic-breast-cancer.html
0 · Reply
letsdodiz
letsdodiz Jul. 16 at 2:02 AM
$BCTX Briacell management has been a low effort team in the last 2-3 years. So to come up with these commercialization PRs l means something. It’s great to see these news while we wait.
0 · Reply
_gatti_
_gatti_ Jul. 15 at 8:52 PM
$BCTX market is sleeping on this. I guess people will buy when this is over $5 . I would like to see some institution buying based on the commercialization news
1 · Reply
rp6577
rp6577 Jul. 15 at 8:43 PM
$BCTX I don’t know about you but I’m pumped $XBI
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 15 at 8:08 PM
$BCTX if you re into biotech, this is a no-brainer. Low market cap. Positive signs fase 3 will be good. Large potential market. Enough cash to go into 2027.
0 · Reply
EscapePlan
EscapePlan Jul. 15 at 6:37 PM
$BCTX Would be nice if this could get above $4 and hold for a bit. Volume is not particularly high, but there seems to be a little confidence that we are going to see a positive update. Look anyway, find any comparison, ask AI, you will get the same answer. If we get a positive update this is going to flip up into the 10s, and then once we get the next BLA etc buy out is highly likely at 20-30+. Still some way to go, probably some more dilution after the readout to get through the next FDA hurdles, but massive derisking and huge upside if (hopefully when) we get the positive interim readout Tempting to buy more warrants at this point....
1 · Reply
Manwiththeplan
Manwiththeplan Jul. 15 at 6:31 PM
$EVAX which will make me rich first? $EVAX or $BCTX ?
1 · Reply
I_H8_SHORTS
I_H8_SHORTS Jul. 15 at 5:56 PM
$BCTX Why are they getting manufacturing in place. Must already have FDA approval or very close to 144 results.
1 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 15 at 4:44 PM
$BCTX is strengthening its path toward potential commercialization by working with FUJIFILM Biotechnologies California on scalable Bria-IMT™ manufacturing. https://www.globenewswire.com/news-release/2026/07/15/3327609/0/en/briacell-arranges-scalable-manufacturing-with-fujifilm-biotechnologies-for-bria-imt.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 15 at 4:30 PM
$BCTX takes another step toward - MOMO'S BREAKOUT BOARD https://investorshangout.com/post/view?id=6837588
0 · Reply
JediGreen
JediGreen Jul. 15 at 3:57 PM
0 · Reply
kaefer
kaefer Jul. 15 at 3:56 PM
$BCTX If I buy, there’ll be a black swan event and this will crash hard… …okay, just did it! GLTA!
0 · Reply
CAN29
CAN29 Jul. 15 at 3:55 PM
$BCTX Great news - curious who is paying Fujifilm and on what terms - might further enhance the news 🤔
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 15 at 3:43 PM
BB's Stock Haven : $BCTX BriaCell reaches another key milestone!... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177789472 via @Investors_Hub
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 15 at 3:35 PM
$BCTX holding 11k @ 3,28. I think my timing could be very well this time. Normally i am 2 years early
2 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 15 at 3:11 PM
BLUE SKY BREAKOUT : Manufacturing matters. $BCTX partnered w... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177789357 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 15 at 2:45 PM
🚨 $BCTX NEWS: BriaCell has arranged scalable manufacturing with FUJIFILM Biotechnologies for Bria-IMT™, supporting its pivotal Phase 3 study and potential future commercial supply. https://www.globenewswire.com/news-release/2026/07/15/3327609/0/en/briacell-arranges-scalable-manufacturing-with-fujifilm-biotechnologies-for-bria-imt.html
0 · Reply
I_H8_SHORTS
I_H8_SHORTS Jul. 15 at 2:36 PM
$BCTX With ONLY 8 Million shares out, it is truly FRIGHTENING to see where this will trade once institutions start loading up. Worth 10x this right now and possibly 100's of times more in the near future.
2 · Reply